In the BioHarmony Drug Report Database

"Preview" Icon

Prednisolone

Delta-cortef, Meti-derm, Sterane (prednisolone) is a small molecule pharmaceutical. Prednisolone was first approved as Delta-cortef on 1982-01-01. It is used to treat adrenal insufficiency, ankylosing spondylitis, asthma, atopic dermatitis, and berylliosis amongst others in the USA. The pharmaceutical is active against glucocorticoid receptor. In addition, it is known to target mineralocorticoid receptor, nuclear receptor subfamily 1 group I member 2, and Ancestral Glucocorticoid Receptor2.

 

Trade Name

 

Delta-cortef, Meti-derm, Sterane
 

Common Name

 

prednisolone
 

ChEMBL ID

 

CHEMBL131
 

Indication

 

adrenal insufficiency, ankylosing spondylitis, asthma, atopic dermatitis, berylliosis, brain neoplasms, collagen diseases, conjunctivitis, dermatitis herpetiformis, edema, erythema multiforme, hemolytic anemia, hypercalcemia, inflammation, leukemia, multiple sclerosis, mycosis fungoides, nephrotic syndrome, pemphigus, pulmonary tuberculosis, rheumatic diseases, sarcoidosis, serum sickness, synovitis, systemic lupus erythematosus, thrombocytopenia, thyroiditis, ulcerative colitis, uveitis
 

Drug Class

 

Prednisone and prednisolone derivatives

Image (chem structure or protein)

Prednisolone structure rendering